Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.

Antiviral research - 1 May 2016

Liu Chia-Chyi, Guo Meng-Shin, Wu Shang-Rung, Lin Hsiao-Yu, Yang Ya-Ting, Liu Wei-Chih, Chow Yen-Hung, Shieh Dar-Bin, Wang Jen-Ren, Chong Pele

Abstract excerpt

Childhood exanthema caused by different serotypes of coxsackievirus (CV-A) and enterovirus A71 (EV-A71) has become a serious global health problem; it is commonly known as hand, foot, and mouth disease (HFMD). Current EV-A71 vaccine clinical trials have demonstrated that human antibody responses generated by EV-A71 vaccinations do not cross-neutralize coxsackievirus A16 (CV-A16). An effective multivalent HFMD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross Reactions
Share to Enterovirus A, Human

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enterovirus Infections

Share to Hand, Foot and Mouth Disease

Share to Vaccines, Inactivated

Share to Viral Tropism

Share to Viral Vaccines

Share to Virion

Source

Identifiers

PMID: 26899790
DOI: 10.1016/j.antiviral.2016.02.008

Genes

SDS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.PMID 26899790Read ↗

Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in miceSemantic proximity Read ↗

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.Semantic proximity Read ↗

Characterization of Coxsackievirus A6 Strains Isolated From Children With Hand, Foot, and Mouth Disease.Semantic proximity Read ↗

A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71Semantic proximity Read ↗

A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like ParticlesSemantic proximity Read ↗

Cryo-electron microscopy and image classification reveal the existence and structure of the coxsackievirus A6 virionSemantic proximity Read ↗

Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.Semantic proximity Read ↗

Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infectionsSemantic proximity Read ↗

Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and ImmunogenicitySemantic proximity Read ↗

Cryo-Electron Microscopy Study of Insect Cell-Expressed Enterovirus 71 and Coxsackievirus A16 Virus-Like Particles Provides a Structural Basis for Vaccine DevelopmentSemantic proximity Read ↗

Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity.Semantic proximity Read ↗

A single amino acid mutation in VP1 of coxsackievirus A6 determining efficiency of VP0 cleavage and proliferation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.